Entrada Therapeutics, Inc. Insider Transactions
Entrada Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 600 @ $18.00 | $10,800 | 183,216 | 10/16/2024 | 10/18/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 847 @ $16.00 | $13,552 | 125,149 | 09/26/2024 | 09/30/2024 | |
| Sell | 3,195 @ $14.97 | $47,832 | 76,486 | 09/09/2024 | 09/10/2024 | ||
|
Dowden Nathan J
President & COO |
Sell | 1,904 @ $15.07 | $28,690 | 125,996 | 09/09/2024 | 09/10/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 2,642 @ $15.09 | $39,862 | 183,816 | 09/09/2024 | 09/10/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 600 @ $15.24 | $9,141 | 186,458 | 09/06/2024 | 09/10/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 399 @ $15.19 | $6,063 | 127,900 | 09/06/2024 | 09/10/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 26,595 @ $16.26 | $432,419 | 130,609 | 08/16/2024 | 08/20/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 502 @ $16.70 | $8,382 | 130,107 | 08/16/2024 | 08/20/2024 | |
|
Doshi Dipal
CEO |
Sell | 1,600 @ $17.81 | $28,497 | 334,475 | 07/15/2024 | 07/16/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 638 @ $18.00 | $11,484 | 188,814 | 07/15/2024 | 07/16/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 600 @ $18.00 | $10,800 | 189,452 | 07/12/2024 | 07/16/2024 | |
|
Doshi Dipal
CEO |
Sell | 300 @ $18.00 | $5,400 | 336,075 | 07/12/2024 | 07/16/2024 | |
| Sell | 1,758 @ $14.95 | $26,282 | 81,412 | 07/08/2024 | 07/10/2024 | ||
|
BAKER BROS. ADVISORS LP
10 percent owner |
Buy | 3,081,303 @ $0.00 | $308 | 3,081,303 | 06/25/2024 | 06/26/2024 | |
|
BAKER BROS. ADVISORS LP
10 percent owner |
Buy | 285,700 @ $0.00 | $29 | 285,700 | 06/25/2024 | 06/26/2024 | |
|
Doshi Dipal
CEO |
Sell | 1,000 @ $16.17 | $16,174 | 336,375 | 06/13/2024 | 06/14/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 9,675 @ $15.19 | $146,944 | 190,052 | 05/20/2024 | 05/20/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 8,305 @ $15.14 | $125,751 | 199,727 | 05/17/2024 | 05/20/2024 | |
|
Doshi Dipal
CEO |
Sell | 1,200 @ $15.11 | $18,129 | 337,375 | 05/17/2024 | 05/20/2024 |
Entrada Therapeutics, Inc. FAQ's
Who is on Entrada Therapeutics, Inc.'s Insider Roster?
The list of insiders at Entrada Therapeutics, Inc. includes Doshi Dipal, Dowden Nathan J, WENTWORTH KORY JAMES, KIM PETER S, Sethuraman Natarajan, BAKER BROS. ADVISORS LP.
How much insider selling is happening at Entrada Therapeutics, Inc.?
Insiders have sold a total of 73,072 Entrada Therapeutics, Inc. shares in the last 12 months for a total of 1.13 M sold.
Which Entrada Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Entrada Therapeutics, Inc. shares in the last 12 months: Doshi Dipal ($126,190), Dowden Nathan J ($511,605), WENTWORTH KORY JAMES ($124,400), Sethuraman Natarajan ($369,782),
How much insider buying is happening at Entrada Therapeutics, Inc.?
Insiders have purchased a total of 3.41 M Entrada Therapeutics, Inc. shares in the last 12 months for a total of 642,276.
Which Entrada Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Entrada Therapeutics, Inc. shares in the last 12 months: KIM PETER S ($641,939), BAKER BROS. ADVISORS LP ($337),